
socialimpactenterprises.co.ukCrawled Oct 16, 2026
Social Impact Enterprises investee, Bloobloom, is on a mission to revolutionise the prescription eyewear industry by offering premium eyewear at affordable prices.
Social Impact Enterprises investee, Kneu Health, a University of Oxford spin-out, on a mission to transform neurological care for millions of patients living with Parkinson's disease and dementia through breakthrough smartphone-based monitoring and AI-powered insights.
Social Impact Enterprises investee, Limitless Travel, stands out for its commitment to making the world more accessible for individuals with mobility challenges.
Social Impact Enterprises investee, Mintago, stood out as a transformative platform tackling the UK’s financial wellbeing crisis.
Bolter focuses on the relationship between people and product, blending anthropology, sensory experience, and design.
IGX12 is a pioneering monoclonal antibody (mAb) with very strong and consistent pre-clinical results and the potential to revolutionize infertility treatment.
Limitless Travel has announced a £6.5m Series A round led by venture capital firm Beringea, alongside Social Impact Enterprises, with participation from Adjuvo, Active Partners, Miroma Ventures, and existing investors including Nigel Wray.
Financial proceeds will be used to advance Igyxos infertility breakthrough treatment towards its goal to transform lives of many facing fertility problems
Origin Coffee announces a £3.1 million investment to support the growth of the business whilst continuing its commitment to improving sustainability within the industry.in the industry.
Social Impact Enterprises features experts with entrepreneurial, operational, and transactional experience supporting socially driven businesses.
The page outlines Social Impact Enterprises’ investments, success stories, and funding criteria for people-driven solutions.
The company offers services and partnerships to help businesses access capital.